ArticleThrombosis journal2026
Incidence and risk factors of deep vein thrombosis in critically ill patients: a systematic review and meta-analysis.
Article in Thrombosis journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDeep vein thrombosis (DVT) is a frequent and often silent complication in intensive care unit (ICU) patients, markedly increasing the risk of pulmonary embolism and death. However, comprehensive quantitative evidence on ICU-DVT incidence and associated risk factors remains scarce.
objectiveTo synthesize global data on the epidemiology of ICU-DVT and identify independent risk factors, providing a basis for evidence-based, risk-stratified prevention.
methodsWe systematically searched PubMed, Embase, Cochrane Library, and Web of Science to July 2024 for observational studies reporting ICU-DVT incidence and risk factors. Pooled odds ratios (ORs) were calculated using random-effects models (PROSPERO ID: CRD42024583844).
resultsA total of 186 studies were included, involving 203,880 ICU patients. The overall incidence of DVT was 10.4% (95% CI 8.9%-12.0%). The incidence was significantly higher in COVID-19 patients than in non-COVID-19 patients (12.4% vs. 8.4%, p < 0.01). Medical ICUs had the highest incidence (16.3%), followed by trauma ICUs (11.6%), general ICUs (10.1%), neuro ICUs (8.6%), and surgical ICUs (7.9%). The incidence varied by region (Asia 12.5%, Europe 11.8%; America 9.3%, Oceania 9.1%). Systematic screening significantly improved DVT detection rates compared with clinically suspected diagnosis (14.6% vs. 7.9%). Meta-analysis revealed that central venous catheterization, a history of DVT, use of vasoactive agents, mechanical ventilation, prolonged ICU stay, and malignancy were associated with increased DVT odds.
conclusionsICU-DVT affects approximately 1 in 10 patients and is associated with distinct modifiable and non-modifiable risk factors. The influence of diagnostic strategies on DVT incidence underscores the necessity for standardized screening in the ICU. Future prospective, large-scale studies are warranted to validate causal relationships and enable the development of risk prediction tools for precision prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.